In the past 10 years, the licit and illicit use of opioids has skyrocketed in the United States and internationally (Kocherlakota, 2014). A large proportion of those affected are reproductive-age women (Ailes et al., 2015), and opioid use during pregnancy has increased fivefold (Patrick et al., 2012), resulting in a dramatic increase in the number of infants born with neonatal abstinence syndrome (NAS) (Klaman et al., 2017; Winkelman, Villapiano, Kozhimannil, Davis, & Patrick, 2018). Infants with NAS require expensive pharmacological and intensive care treatment after birth (Winkelman et al., 2018), and they are at increased risk for a range of behavioral and neurodevelopmental problems (Lee, Pritchard, Austin, Henderson, & Woodward, 2020; Levine & Woodward, 2017; McGlone & Mactier, 2015; Nygaard, Slinning, Moe, & Walhovd, 2016; Stover & Davis, 2015). NAS is particularly prominent in the southeastern United States (that is, Tennessee, Kentucky, Mississippi, West Virginia, and Alabama), with incidence rates of up to 5.06 percent of all live hospital births (compared with 0.73 percent nationally; Brown, Doshi, Pauly, & Talbert, 2016; Erwin, Meschke, Ehrlich, & Lindley, 2017; Patrick, Davis, Lehmann, & Cooper, 2015). In our geographic catchment area in rural Tennessee, the highest incidence rates were reported in 2017 for Sullivan County, the North East and East Health regions, Upper Cumberland, and Knox County (up to 9.3 percent); however, a decrease in NAS rates was observed in 2018 (Miller & McDonald, 2019).